SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 220 filers reported holding SAGE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $450 | -99.9% | 10,721 | -20.9% | 0.04% | -35.7% |
| Q3 2022 | $531,000 | -12.4% | 13,557 | -27.7% | 0.07% | -23.1% |
| Q2 2022 | $606,000 | -45.3% | 18,750 | -28.0% | 0.09% | -34.5% |
| Q4 2021 | $1,108,000 | +198.7% | 26,035 | +211.0% | 0.14% | +265.8% |
| Q3 2021 | $371,000 | -62.4% | 8,371 | -51.8% | 0.04% | -65.8% |
| Q2 2021 | $987,000 | +75.9% | 17,381 | +167.9% | 0.11% | +20.7% |
| Q4 2020 | $561,000 | +93.4% | 6,487 | +36.7% | 0.09% | +91.7% |
| Q3 2020 | $290,000 | -52.8% | 4,744 | -77.8% | 0.05% | -68.8% |
| Q1 2020 | $614,000 | +38.0% | 21,374 | +246.6% | 0.15% | +196.2% |
| Q4 2019 | $445,000 | +8.8% | 6,167 | +10.1% | 0.05% | +225.0% |
| Q2 2015 | $409,000 | – | 5,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |